Literature DB >> 9880562

Identification and characterization of the cis-acting elements of the human CD155 gene core promoter.

D Solecki1, E Wimmer, M Lipp, G Bernhardt.   

Abstract

The CD155 protein is the founding member of a new group of related molecules within the immunoglobulin superfamily sharing a V-C2-C2 domain structure and significant amino acid identity. We have recently isolated the promoter of the CD155 gene so that we may determine the transcription factors that regulate its expression and possibly gain insight into the cell biology of this gene. Here we report the mapping of three cis-elements within the CD155 core promoter, designated FPI, II, and III. The results of linker scanning mutagenesis suggest that all three of these cis-elements are required in varying degrees for the promoter activity of the core promoter fragment. The relative contribution of each region ranked in the following order: III > II > I. Interestingly, footprint and electrophoretic mobility shift assays show that FPIII binding activity is much reduced in a human cell line that does not express CD155. Additionally, protein binding to FPI and FPII was also investigated. DNase I footprinting using recombinant hAP-2alpha indicated that this transcription factor bound to both the FPI and FPII regions of the CD155 core promoter fragment. Electrophoretic mobility shift assays and supershift analysis confirmed the binding of AP-2 from crude nuclear extracts to FPI and to FPII. Lastly, cotransfection of the CD155 promoter with an AP-2alpha expression vector indicates that overexpression of AP-2alpha modulated the promoter activity of a CD155 promoter construct.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9880562     DOI: 10.1074/jbc.274.3.1791

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Oncolytic poliovirus against malignant glioma.

Authors:  Christian Goetz; Elena Dobrikova; Mayya Shveygert; Mikhail Dobrikov; Matthias Gromeier
Journal:  Future Virol       Date:  2011-09       Impact factor: 1.831

2.  Overexpression of the CD155 gene in human colorectal carcinoma.

Authors:  D Masson; A Jarry; B Baury; P Blanchardie; C Laboisse; P Lustenberger; M G Denis
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

3.  Poliovirus receptor CD155-targeted oncolysis of glioma.

Authors:  Melinda K Merrill; Guenter Bernhardt; John H Sampson; Carol J Wikstrand; Darell D Bigner; Matthias Gromeier
Journal:  Neuro Oncol       Date:  2004-07       Impact factor: 12.300

4.  Prognostic significance of CD155 mRNA expression in soft tissue sarcomas.

Authors:  Satoru Atsumi; Akihiko Matsumine; Hidemi Toyoda; Rui Niimi; Takahiro Iino; Akihiro Sudo
Journal:  Oncol Lett       Date:  2013-04-02       Impact factor: 2.967

5.  Genome-wide computational prediction and analysis of core promoter elements across plant monocots and dicots.

Authors:  Sunita Kumari; Doreen Ware
Journal:  PLoS One       Date:  2013-10-29       Impact factor: 3.240

6.  Oral poliovirus vaccine-induced programmed cell death involves both intrinsic and extrinsic pathways in human colorectal cancer cells.

Authors:  Sareh Zhand; Seyed Masoud Hosseini; Alijan Tabarraei; Mohsen Saeidi; Marie Saghaeian Jazi; Mohamad Reza Kalani; Abdolvahab Moradi
Journal:  Oncolytic Virother       Date:  2018-10-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.